Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 3,391.26 | 1,630.33 | 2,912.28¢ | 16.9 | 2.2 | +8% | n/a | 0.0% |
| 31-Dec-27 | 3,704.84 | 1,745.10 | 3,075.24¢ | 16.0 | 2.9 | +6% | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| GlaxoSmithKline reportedly running the ruler ove... | 04-Aug-2017 | ShareCast |
| Contracting | 06-Dec-2007 | Washington Post |
| United Therapeutics Shares Soar on FDA Report | 02-Nov-2007 | Washington Post |
| Study Raises Questions For United Therapeutics | 27-Feb-2007 | Washington Post |
| Currency | US Dollars |
| Share Price | $ 490.83 |
| Change Today | $ -12.86 |
| % Change | -2.55 % |
| 52 Week High | $517.13 |
| 52 Week Low | $274.70 |
| Volume | 329,861 |
| Shares Issued | 43.56m |
| Market Cap | $21,382m |
| RiskGrade | 132 |
| Strong Buy | 6 |
| Buy | 3 |
| Neutral | 6 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 15 |

| Time | Volume / Share Price |
| 15:59 | 100 @ $490.97 |
| 15:59 | 40 @ $490.92 |
| 15:59 | 100 @ $490.91 |
| 15:59 | 40 @ $490.71 |
| 15:59 | 64 @ $490.60 |
You are here: research